Brain Changes in Neurodegenerative Diseases: A Tracking Study
Part of Brain & nervous system, Eyes & vision, Hormones & metabolism, Mental health clinical trials.
This research study tracks how brain damage progresses in rare neurodegenerative diseases like frontotemporal dementia, primary progressive aphasia, PSP, CBS, and ALS. Researchers use brain imaging and tests to understand how these diseases spread in the brain, which could help develop better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 84 years old
- You have been diagnosed with one of these specific brain diseases: bvFTD, semantic variant PPA, non-fluent variant PPA, PSP, CBS, or early-stage ALS—or you are a healthy family member of someone with a genetic form of these diseases
- You do not have a history of other neurological or psychiatric disorders (such as Parkinson's, Alzheimer's, schizophrenia, or depression)
- You have not had a significant head injury or history of serious alcohol or drug use
- You do not have a family history of other neurodegenerative diseases
- If you are a healthy participant, you must be between 20 and 30 years old, or matched in age and sex to an enrolled patient
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information from people with neurodegenerative diseases, some family members, and healthy controls to help researchers better understand these conditions. It may help future diagnosis and research, and participation may include noninvasive checks and other procedures depending on your situation.
This study follows people with frontotemporal dementia (FTLD) and related conditions, and collects health and (for some people) body fluid information, to understand how these illnesses change over time. It may help researchers track disease signs and find better ways to measure progression.
This study uses a special PET/CT brain scan to look at a protein called tau in people with memory/thinking and movement disorders. The results may help researchers understand how these diseases affect the brain and improve future diagnosis or care.
This study looks at genetic factors in people with PSP, CBS, MSA, or similar brain conditions, and also in their family members. It involves genetic testing to learn more about these diseases and may help find new treatments.
This study is looking for proteins in blood and other body fluids that could help detect brain diseases like Parkinson's, Alzheimer's, and ALS early. It aims to improve diagnosis and future treatments.
This study is looking for people with neurodegenerative diseases (like Alzheimer's, Parkinson's, ALS) to help researchers find new markers in the body that could help understand these conditions better and possibly lead to better treatments.
Hear when a new Neurodegenerative Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.